Related Info
Browse Other Research Papers
- Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. J Thromb Thrombolysis. 2009 Nov 17. [Epub ahead of print]
- Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients Results From the EVENT Registry. JACC Cardiovasc Interv. 2009 Nov;2(11):1074-1082.
- Trajectories of Entering the Metabolic Syndrome. The Framingham Heart Study. Circulation. 2009 Nov 2. [Epub ahead of print]
- Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo. Psychopharmacol Bull. 2009;42(3):21-35.
- What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009 Nov;60(11):1439-45.
- Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. Int Clin Psychopharmacol. 2009 Nov;24(6):296-305.
Meet The HCRI Team
Peter Zimetbaum, MD
Director of ECG and Arrhythmia Core Laboratory
Dr. Zimetbaum is Director of Clinical Cardiology at Beth Israel Deaconess Medical Center and also Associate Professor of Medicine at…
Submit an RFP
Quick Links
930-W Commonwealth Avenue
Boston MA 02215
t: 617.632.1515 f: 617.632.1580
©2009 Harvard Clinical Research Institute